United States HR 6483: Improved Transparency of Foreign Drug Manufacturing Act of 2022

Status: Referred to the Subcommittee on Health. (as of 2022-01-26)

State: United States · Session: 117 · Bill: HR 6483

Sponsors: ANNA G. ESHOO

View United States HR 6483 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.